This study provides valuable insights into how USP30-AS1 influences immune cell infiltration and aims to provide a comprehensive understanding of its role in tumor progression and its potential application in targeted therapies for ovarian cancer. This evidence concerns the gene USP30 and ovarian carcinoma.